Managed Account Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Managed Account Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$3.16M	Buy	285,380 +48,220	+20%	+$532K	﹤0.01%	1640
2015 Q1	$2.71M	Buy	237,160 +47,090	+25%	+$500K	﹤0.01%	1711
2014 Q4	$1.92M	Sell	190,070 -4,870	-2%	-$51.3K	﹤0.01%	1833
2014 Q3	$2.05M	Buy	194,940 +12,095	+7%	+$114K	﹤0.01%	1797
2014 Q2	$1.58M	Buy	182,845 +9,705	+6%	+$81.6K	﹤0.01%	1862
2014 Q1	$1.52M	Sell	173,140 -3,780	-2%	-$32.9K	﹤0.01%	1832
2013 Q4	$1.45M	Buy	176,920 +8,940	+5%	+$70.8K	﹤0.01%	1812
2013 Q3	$1.27M	Buy	167,980 +35,945	+27%	+$261K	﹤0.01%	1831
2013 Q2	$999K	Buy	+132,035	New	+$964K	﹤0.01%	1867

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCM

Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Managed Account Advisors's RDY Position: Q2 2015 in Review

Managed Account Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 20% in Q2 2015, buying an estimated $532K and bringing the position to 285,380 shares worth $3.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Managed Account Advisors first reported a position in RDY in Q2 2013 and has held it in 9 quarters since. 190 funds tracked by Wall St. Rank hold RDY as of Q2 2015.

Managed Account Advisors held 285,380 shares of Dr. Reddy's Laboratories worth $3.16M as of Q2 2015.
Managed Account Advisors bought 48,220 Dr. Reddy's Laboratories shares in Q2 2015, an estimated $532K.
Dr. Reddy's Laboratories made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1640 holding.
Managed Account Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 9 quarters since.
190 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.